ADHD: A new practice guideline from the American Academy of Pediatrics. Attention deficit hyperactive disorder.
作者信息
Bauchner H
出版信息
Arch Dis Child. 2000 Jul;83(1):63. doi: 10.1136/adc.83.1.63.
Abstract
摘要
相似文献
1
ADHD: A new practice guideline from the American Academy of Pediatrics. Attention deficit hyperactive disorder.注意力缺陷多动障碍：美国儿科学会的一项新实践指南。注意力缺陷多动障碍。
Arch Dis Child. 2000 Jul;83(1):63. doi: 10.1136/adc.83.1.63.
2
The new attention deficit hyperactivity disorder clinical practice guidelines published by the American Academy of Pediatrics.美国儿科学会发布的新版注意力缺陷多动障碍临床实践指南。
J Dev Behav Pediatr. 2012 Jan;33(1):76-7. doi: 10.1097/DBP.0b013e318241eadf.
3
ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.ADHD：儿童和青少年注意缺陷多动障碍的诊断、评估和治疗的临床实践指南。
Pediatrics. 2011 Nov;128(5):1007-22. doi: 10.1542/peds.2011-2654. Epub 2011 Oct 16.
4
Childhood and adolescent attention-deficit hyperactivity disorder: diagnosis, clinical practice guidelines, and social implications.儿童及青少年注意力缺陷多动障碍：诊断、临床实践指南及社会影响
J Am Acad Nurse Pract. 2009 Sep;21(9):488-97. doi: 10.1111/j.1745-7599.2009.00438.x.
5
The assessment of attention-deficit/hyperactivity disorder in rural primary care: the portability of the American Academy of Pediatrics guidelines to the "real world".农村基层医疗中注意力缺陷/多动障碍的评估：美国儿科学会指南在“现实世界”中的适用性
Pediatrics. 2005 Feb;115(2):e120-6. doi: 10.1542/peds.2004-1521.
6
Pediatricians need more help with ADHD diagnostic guidelines.儿科医生在多动症诊断指南方面需要更多帮助。
Rep Med Guidel Outcomes Res. 2004 Aug 20;15(16):1, 5-6.
7
Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.儿童和青少年注意缺陷多动障碍的诊断、评估和治疗临床实践指南。
Pediatrics. 2019 Oct;144(4). doi: 10.1542/peds.2019-2528.
8
Diagnosis and treatment of ADHD in school-age children in primary care settings: a synopsis of the AAP Practice Guidelines. American Academy of Pediatrics.
Pediatr Rev. 2003 Mar;24(3):92-8. doi: 10.1542/pir.24-3-92.
9
Practice patterns and guideline adherence in the management of attention deficit/hyperactivity disorder.注意缺陷多动障碍管理中的实践模式与指南遵循情况
Clin Pediatr (Phila). 2014 Sep;53(10):960-6. doi: 10.1177/0009922814540985. Epub 2014 Jun 30.
10
A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.一个就注意力缺陷/多动障碍的诊断和管理达成社区共识的过程。
Pediatrics. 2005 Jan;115(1):e97-104. doi: 10.1542/peds.2004-0953.
引用本文的文献
1
Association of symptoms of attention-deficit/hyperactivity disorder with physical activity, media time, and food intake in children and adolescents.注意缺陷多动障碍症状与儿童和青少年身体活动、媒体时间和食物摄入的关联。
PLoS One. 2012;7(11):e49781. doi: 10.1371/journal.pone.0049781. Epub 2012 Nov 14.
2
The effects of patient characteristics on ADHD diagnosis and treatment: a factorial study of family physicians.患者特征对 ADHD 诊断和治疗的影响：家庭医生的析因研究。
BMC Fam Pract. 2010 Feb 8;11:11. doi: 10.1186/1471-2296-11-11.
3
The QT interval and psychotropic medications in children: recommendations for clinicians.儿童的QT间期与精神药物：给临床医生的建议
Eur Child Adolesc Psychiatry. 2007 Feb;16(1):33-47. doi: 10.1007/s00787-006-0573-0. Epub 2006 Aug 29.
4
An episode-based framework for analyzing health care expenditures: an application of reward renewal models.一种基于事件的医疗保健支出分析框架：奖励更新模型的应用
Health Serv Res. 2005 Dec;40(6 Pt 1):1953-71. doi: 10.1111/j.1475-6773.2005.00452.x.
本文引用的文献
1
Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder.注意缺陷多动障碍儿童治疗反应的调节因素和中介因素：注意缺陷多动障碍儿童多模式治疗研究
Arch Gen Psychiatry. 1999 Dec;56(12):1088-96. doi: 10.1001/archpsyc.56.12.1088.
2
A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.一项针对注意力缺陷/多动障碍治疗策略的14个月随机临床试验。MTA合作组。多动症儿童的多模式治疗研究。
Arch Gen Psychiatry. 1999 Dec;56(12):1073-86. doi: 10.1001/archpsyc.56.12.1073.
3
L-carnitine in children with idiopathic dilated cardiomyopathy.
Indian Heart J. 1998 Jan-Feb;50(1):59-61.
4
Molecular basis of dystrophic epidermolysis bullosa: mutations in the type VII collagen gene (COL7A1).营养不良性大疱性表皮松解症的分子基础：VII型胶原蛋白基因（COL7A1）的突变
Hum Mutat. 1997;10(5):338-47. doi: 10.1002/(SICI)1098-1004(1997)10:5<338::AID-HUMU2>3.0.CO;2-B.
5
Molecular and immune mechanisms in the pathogenesis of cardiomyopathy--role of viruses, cytokines, and nitric oxide.心肌病发病机制中的分子和免疫机制——病毒、细胞因子及一氧化氮的作用
Jpn Circ J. 1997 Apr;61(4):275-91. doi: 10.1253/jcj.61.275.
6
Fatal cardiomyopathy in dystrophic epidermolysis bullosa.营养不良性大疱性表皮松解症中的致命性心肌病。
Br J Dermatol. 1996 Oct;135(4):603-6.
7
Gastrostomy and growth in dystrophic epidermolysis bullosa.
Br J Dermatol. 1996 May;134(5):872-9.
8
Reversible cardiomyopathy due to carnitine deficiency from renal tubular wasting.由于肾小管性损耗导致肉碱缺乏引起的可逆性心肌病。
Pediatr Cardiol. 1995 Mar-Apr;16(2):76-8. doi: 10.1007/BF00796822.
9
Keshan disease: an endemic cardiomyopathy in China.克山病：中国的一种地方性心肌病。
Hum Pathol. 1985 Jun;16(6):602-9. doi: 10.1016/s0046-8177(85)80110-6.
10
Echocardiography of intracardiac filling defects in infants and children.婴幼儿心内充盈缺损的超声心动图检查
Pediatr Cardiol. 1986;7(4):189-94. doi: 10.1007/BF02093177.
Zotero 插件